Legal Opinion

Mylan Pharmaceuticals Inc., Mylan Specialty L.P., and Mylan Inc. v. Sanofi-Aventis U.S. LLC, Aventis Pharma S.A., and Sanofi-Aventis Puerto Rico Inc.

District Court, W.D. Pennsylvania

Decided January 27, 2026No. 2:23-cv-00836Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA MYLAN PHARMS. INC. ET AL, ) ) Plaintiffs, ) ) 2:23-cv-00836 v. ) ) SANOFI-AVENTIS U.S. LLC ET AL, ) ) Defendants. ) ) OPINION Mark R. Hornak, United States District Judge This case involves a dispute between two large players in the pharmaceutical industry over the injectable insulin glargine market. Plaintiffs Mylan Pharmaceuticals Inc., Mylan Specialty L.P., and Mylan Inc. (collectively “Mylan”1 or “Plaintiffs”) brought suit against Sanofi S.A., Sanofi-Aventis U.S. LLC, Aventis Pharma S.A., and Sanofi-Aventis…

2Cases cited84 opinions

  1. Ashcroft v. IqbalSupreme Court of the United States · 2009
  2. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  3. International Shoe Co. v. WashingtonSupreme Court of the United States · 1945
  4. Swierkiewicz v. Sorema N. A.Supreme Court of the United States · 2002
  5. Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008

79 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API